Should Biotechnology Stock Ambrx Biopharma Inc (AMAM) Be in Your Portfolio Thursday?

Thursday, November 30, 2023 11:05 AM | InvestorsObserver Analysts

Mentioned in this article

Should Biotechnology Stock Ambrx Biopharma Inc (AMAM) Be in Your Portfolio Thursday?

The 81 rating InvestorsObserver gives to Ambrx Biopharma Inc (AMAM) stock puts it near the top of the Biotechnology industry. In addition to scoring higher than 97 percent of stocks in the Biotechnology industry, AMAM’s 81 overall rating means the stock scores better than 81 percent of all stocks.

AMAM has an Overall Score of 81. Find out what this means to you and get the rest of the rankings on AMAM!

See Full AMAM Report

What do These Ratings Mean?

Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. InvestorsObserver makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts. This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

What's Happening With Ambrx Biopharma Inc Stock Today?

Ambrx Biopharma Inc (AMAM) stock is trading at $12.80 as of 10:53 AM on Thursday, Nov 30, a gain of $1.08, or 9.22% from the previous closing price of $11.72. The stock has traded between $12.40 and $13.22 so far today. Volume today is less active than usual. So far 562,879 shares have traded compared to average volume of 1,019,849 shares. Click Here to get the full Stock Report for Ambrx Biopharma Inc stock.